← FDA Drug Approvals (Drugs@FDA)

OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: ACCORD HLTHCARE · Approved 2019-02-07

Drug application

FDA Application #

ANDA209281

Application type

Abbreviated New Drug Application (Generic)

Brand name

OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE

Generic name

OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE

Active ingredients

HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL

Dosage form

TABLET

Route

ORAL

Marketing status

Prescription

Sponsor

ACCORD HLTHCARE

Manufacturer

Accord Healthcare Inc.

First approval

2019-02-07

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown